Back
Sep 30
Poster Q & A
PQA 08 - Gastrointestinal Cancer, Nonmalignant Disease, Palliative Care
Presentations
-
02:30pm - 03:45pm PT
10-year Experience of Ultra-Hypofractionated SBRT for Adrenal Metastases
Speaker: Edward Chmiel, MD - Peter MacCallum Cancer Institute, East Melbourne -
02:30pm - 03:45pm PT
3-Dimensional Treatment Planning and Target Volume Definition of Osteoarthritis - Recommendations of the International Benign Target Volume Peer Group
Speaker: David Rene Steike, MD - Department of Radiation Therapy – Radiation Oncology, University Hospital of Muenster, Muenster -
02:30pm - 03:45pm PT
A Large Animal Study of a Novel Cardiac-Ultrasound Image Guidance for Cardio-Respiratory-Gated Radiation Ablation to Ventricular Tachycardia Targets Using Proton Therapy
Speaker: Yen-Lin Evelyn Chen, MD - Massachusetts General Hospital, Boston -
02:30pm - 03:45pm PT
A Longitudinal CT-Based Subregional Radiomics Nomogram for Predicting Local Recurrence-Free Survival in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy: A Multicenter Study
Speaker: Jie Gong, PhD - Department of Radiation Oncology, Xijing Hospital, Air Force Medical University. Xi’an, China, Xian -
02:30pm - 03:45pm PT
A Machine Learning Model Based on Computed Tomography Radiomics for the Prediction of the Response to SBRT in Lung Metastasis from Colorectal Cancer
Speaker: Donatella Caivano, MD - San Giovanni Addolorata Hospital - Rome, Roma RM -
02:30pm - 03:45pm PT
A Multi-Dimensional Deep Ensemble Learning Model Predicts Pathological Response and Treatment Outcomes to Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Pretreatment CT Images: A Multicenter, Retrospective Cohort Study
Speaker: Yunsong Liu, MD - National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC, Beijing -
02:30pm - 03:45pm PT
A Novel Tool to Predict Primary Tumor Location in the Setting of Metastatic Cancer with Unknown Primary
Speaker: Kerolous Eldeeb, MS - Case Western Reserve School of Medicine, Cleveland -
02:30pm - 03:45pm PT
A Preliminary Investigation into the Clinical Application of Magnetic Resonance Linear Accelerator for Treating Hepatocellular Carcinoma and Colorectal Cancer Liver Metastasis
Speaker: Yuan Zong, MD - Department of Radiation Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing -
02:30pm - 03:45pm PT
A Prospective Study of CT-Guided and 3D-Printing Template-Assisted Implantation of Fiducial Markers in the Pancreatic Carcinoma for Stereotactic Body Radiation Therapy (FIRST-1 Study)
Speaker: Yi Chen, MD - Peking University Third Hospital, Beijing -
02:30pm - 03:45pm PT
Abdominal Compression as an Alternative Positioning Strategy to Decrease OAR Doses in Rectal Cancer Patients Treated with Neoadjuvant Radiotherapy
Speaker: Melisa Bagci Kilic, MD - Marmara University School of Medicine, Istanbul -
02:30pm - 03:45pm PT
Ablative Radiotherapy for Inoperable Non-Metastatic Pancreatic Cancer: Long-Term Results in a Single Center
Speaker: Jing Wang, MD, PhD - Chinese PLA General Hospital, Beijing -
02:30pm - 03:45pm PT
Achievable Dosimetry for the Anterior Vaginal Wall and Bulboclitorus with Vaginal Dilator Use in Pelvic Radiotherapy for Anal and Rectal Cancers
Speaker: Aoi Shimomura, MD - Cedars-Sinai Department of Radiation Oncology, Los Angeles -
02:30pm - 03:45pm PT
Analysis of Treatment Patterns and Prognostic Factors in Patients with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma
Speaker: Hanyu Si, - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang City -
02:30pm - 03:45pm PT
Analysis of Urgent Starts for Radiotherapy that Occur on Weekends at an Academic Institution
Speaker: Matthew Charles, MD - University of Wisconsin Hospitals and Clinics, Madison -
02:30pm - 03:45pm PT
Association of Central Hepatobiliary Tract Radiation Dose and Hepatobiliary Outcomes after MRI-Guided Liver Stereotactic Body Radiotherapy
Speaker: Patrick Courtney, MD, MAS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles -
02:30pm - 03:45pm PT
Association of Skeletal Muscle and Adiposity Measured by Computed Tomography with Toxicity and pCR in Esophageal Squamous Cell Carcinoma Receiving Standardized Neoadjuvant Chemoradiotherapy
Speaker: Wei-Xiang Qi, MD, RT - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai -
02:30pm - 03:45pm PT
Barriers and Facilitators to Anal Cancer Screening and Treatment for Patients with HIV: Physician Perceptions and Practices
Speaker: Sarah Blake, PhD - Emory University, Rollins School of Public Health, Atlanta -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Breaking the Stigma: Oncology Providers Weigh in on Psychedelic-Assisted Therapy
Speaker: Akul Munjal, MD - University of California irvine, Orange -
02:30pm - 03:45pm PT
Carbon-Ion Radiotherapy for Elderly Patients with Locally Advanced Pancreatic Cancer
Speaker: Kotaro Terashima, MD, PhD - Ion Beam Therapy Center, SAGA-HIMAT Foundation, Tosu -
02:30pm - 03:45pm PT
Cardiomyocytes Upregulated the PD-L1 Expression to Alleviate Cardiac Injury Induced by Irradiation Combined with Anti-PD-1 Antibody: An In Vitro and In Vivo Study
Speaker: Jun Wang, MD, PhD - The Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Changes in Apparent Diffusion Coefficient After Radiation Therapy for Bone Metastases: A Comparative Study of SBRT and Conventional RT
Speaker: Osamu Tanaka, MD, PhD - Asahi Univeristy Hospital, Gifu city -
02:30pm - 03:45pm PT
Chronotherapeutic Effects of Immune Checkpoint Inhibitors and Stereotactic Body Radiotherapy: Secondary Analysis of a Prospective Trial
Speaker: Aashka Mehta, - The University of Chicago, Chicago -
02:30pm - 03:45pm PT
Circulating Tumor DNA Dynamics as Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma(ESCC) Receiving Definitive Radiotherapy: A Prospective Cohort Study
Speaker: Rutian Cheng, - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Cistern-Guided Radiosurgery: Personalized Dose Adaptation for Young Medically Refractory Trigeminal Neuralgia Patients
Speaker: Vangipuram Shankar, MD, MBBS - C r reddy superspeciality hospital, Nellore -
02:30pm - 03:45pm PT
Clinical and Dosimetric Predictors for Radiation-Induced Acute Upper Gastrointestinal Bleeding in Patients with Hepatocellular Carcinoma Undergoing Proton or Photon Radiation Therapy
Speaker: Willy, Po-Yuan Chen, MD - Linkou Chang Gung Memorial Hospital, Taoyuan -
02:30pm - 03:45pm PT
Clinical Application of Simultaneous Integrated Boost in Stereotactic Body Radiotherapy for Large-Volume Tumors: A Single-Center Retrospective Study
Speaker: Min Zhao, - The First Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Clinical Benefit of Adding Irinotecan to Standard Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis
Speaker: Botian Zhao, - The Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Clinical Benefits of Postoperative Adjuvant Immunotherapy for Resectable Locally Advanced Esophageal Cancer
Speaker: Cong Li, MD - Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Cancer Hospital, Chongqing -
02:30pm - 03:45pm PT
Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation-Induced Lymphopenia
Speaker: Yifu Ma, - The Second Affiliated Hospital of Soochow University, Suzhou -
02:30pm - 03:45pm PT
Clinical Outcomes and Patterns of Failures of Patients with Oligometastatic Anal Squamous Cell Carcinoma Treated with Definitive-Intent Chemoradiation and Metastasis-Directed Therapy
Speaker: Revathi Ravella, MD - Memorial Sloan Kettering Cancer Center, New York -
02:30pm - 03:45pm PT
Clinical Outcomes and Safety of the Combination of External Beam Radiotherapy with <sup>177</sup>Lu-DOTATATE
Speaker: Abigail Pepin, MD - University of Pennsylvania Health System, Philadelphia -
02:30pm - 03:45pm PT
Clinical Outcomes of SBRT for Oligometastatic Bone Disease and the Risk Factor of Local Recurrence
Speaker: Katsuyuki Shirai, MD, PhD - Gunma University, Maebashi -
02:30pm - 03:45pm PT
Combining Lu177-PSMA and External Beam Radiation Therapy: A Retrospective Safety Analysis
Speaker: Desiree Rafizadeh, BS - University of California, Irvine, School of Medicine, Irvine -
02:30pm - 03:45pm PT
Treatment Outcomes and Prognostic Factors in Young-Onset Rectal Cancer
Speaker: Daniel Hong, MD - Washington University in St. Louis, St. Louis -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Comparative Evaluation of Quality of Life with EORTC-CR29 QoL Questionnaire between Nonoperative Management and Surgical Patients Following Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Speaker: Ugur Selek, MD, FASTRO, Prof. - Koc University, School of Medicine, Istanbul, Turkey, Istanbul -
02:30pm - 03:45pm PT
Comparing Stereotactic Body Radiation Therapy and Hypofractionated Radiation for Unresectable Intrahepatic and Perihilar Cholangiocarcinoma: A Retrospective Analysis
Speaker: Bryn Myers, MD - Cleveland Clinic Foundation, Cleveland -
02:30pm - 03:45pm PT
Correlation between Adverse Events Therapeutic Response and Microbiome Changes
Speaker: Márton Barabás, MD - University of Debrecen, Debrecen -
02:30pm - 03:45pm PT
Correlation between Pan-Immune Inflammation Value Dynamics and Magnetic Resonance Imaging Response in Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy
Speaker: Ugur Selek, MD, FASTRO, Prof. - Koc University, School of Medicine, Istanbul, Turkey, Istanbul -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
CoVART: A Retrospective Cohort Study of Conventionally Fractionated RT vs. Ablative RT Dosing in the Treatment of Locally Advanced Pancreatic Cancer
Speaker: Elizabeth Ademuwagun, MD - Temple University Hospital/Fox Chase Cancer Center, Philadelphia -
02:30pm - 03:45pm PT
CT-Based Target Delineation and Low-Dose Radiotherapy for Knee Osteoarthritis - A Single Center Experience
Speaker: Yu-Hsuan Chuang, MD - Far Eastern Memorial Hospital, New Taipei City -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Developing a Novel Staging System that Incorporates the Circumferential Resection Margin into the ypT Stage Could Improve the Accuracy of Survival Prediction for Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
Speaker: Wan-Hsuan Chow, MD - Chi Mei Medical Center, Yungkang City 701 44 -
02:30pm - 03:45pm PT
Development and Analysis of a Nomogram Based on Prognostic Factors in Locally Advanced Esophagogastric Junction Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy
Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Differential Dose-Volume Indices-Based Machine Learning Model for Severe Radiation-Induced Lymphopenia in Patients with Upper Abdominal Malignancies
Speaker: Yuanlin Li, - Shandong Cancer Hospital and Institute, Jinan -
02:30pm - 03:45pm PT
Does Thoracic Radiotherapy Combined with Immune Checkpoint Inhibitors Increase Cardiac Toxicity? — A Systemic Review and Meta-Analysis
Speaker: Jun Wang, MD, PhD - The Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Dose Accumulation and Geometric Variation of Local Recurrence in Anal Cancer Patients Receiving Concurrent Chemoradiation
Speaker: Jasmine Chen, MS, RT - Princess Margaret Cancer Centre, Toronto -
02:30pm - 03:45pm PT
Dose-Volume Constraints Associated with Liver Toxicity in Patients with Small Livers Receiving Liver Stereotactic Body Radiation Therapy
Speaker: Eric Hsu, MD, PhD - Stanford Health Care, Stanford -
02:30pm - 03:45pm PT
Dosimetric Comparison of Carbon Ion Beam Therapy and SBRT for Ventricular Arrhythmia
Speaker: Mayumi Ichikawa, MD, PhD - Yamagata University School of Medicine, Yamagata -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Durable Local Control of Adding Palliative Radiotherapy to Nivolumab for Advanced Esophageal Cancer
Speaker: Takeshi Fujisawa, MD, PhD - National Cancer Center Hospital East, Kashiwa-shi -
02:30pm - 03:45pm PT
Early Clinical Results of Spatially Fractionated Radiation Therapy (SFRT) with GRID in the Treatment of Bulky/Advanced Tumors
Speaker: Natalie Wong, MBBS, MRes(Med), FRCR - Tuen Mun Hospital, Hong Kong -
02:30pm - 03:45pm PT
Early Outcomes of Dose-Escalated Radiation Therapy for Pancreatic Cancer
Speaker: I-Chia Liu, MD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Baltimore -
02:30pm - 03:45pm PT
Effect of Prophylactic Thrombopoietin and Magnetic Resonance Guided Bone Marrow-Sparing Concurrent Chemoradiotherapy on Thrombocytopenia for Thoracic Esophageal Cancer: Final Analysis of a Phase II Study
Speaker: Yupei Yuan, MD - Cancer Hospital Chinese Academy of Medical Sciences, Beijing -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Efficacy and Safety of Neoadjuvant Therapies in Locally Advanced Esophageal Squamous Cell Carcinoma: A Comprehensive Retrospective Analysis
Speaker: Likun Liu, MD - Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Efficacy and Safety of Stereotactic Intensity-Modulated Proton Therapy (SIMPT) in Unresectable Hepatocellular Carcinoma
Speaker: Thinnakorn Chomchai, MD - King Chulalongkorn Memorial Hospital, Bangkok -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Trends in Local Therapy for Hepatocellular Carcinoma from 2004-2019: An NCDB Analysis
Speaker: Benjamin Tran, MD - Mount Sinai Hospital, New York -
02:30pm - 03:45pm PT
Ending the HIV Epidemic with Low Dose Total Body Irradiation in Combination with Anti-Microtubule Therapy
Speaker: Kati Doxsee, PhD - Prisma Health- Upstate Cancer Institute, Greenville -
02:30pm - 03:45pm PT
Endobronchial HDR Brachytherapy for Post-Transplant or Wegeners Granulomatosis Associated Bronchial Stenosis: Extended Follow-up of Pulmonary Function, Subsequent Procedures, and Second Malignancy
Speaker: Dana Schaar, - University of Pittsburgh School of Medicine, Pittsburgh -
02:30pm - 03:45pm PT
Escalated-Dose Ablative Radiation Therapy for Oligometastatic Pancreatic Cancer: A Single-Institution Experience
Speaker: Mustafa Basree, DO, MS - University of Wisconsin Hospitals and Clinics, Madison -
02:30pm - 03:45pm PT
Evaluating KPIs in Palliative Care: Insights from a Tertiary Center
Speaker: Nandan Shanbhag, MD - Tawam Hospital, Abu Dhabi -
02:30pm - 03:45pm PT
Evaluation of Short-Term Efficacy and Long-Term Prognostic Factors Following Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
Speaker: Linlin Xiao, MS - the fourth hospital of hebei medical university, Shijiazhuang -
02:30pm - 03:45pm PT
Exercise Enhancement after Radiotherapy for Bone Metastases: A Phase I Feasibility Trial for Patients with Painful Non-Spine Bone Metastases (EXERT-BM)
Speaker: Michael Yan, MD - Princess Margaret Cancer Center, University Health Network, Toronto -
02:30pm - 03:45pm PT
Exploratory Analysis of PET and CA 19-9 Response in Pancreatic Ductal Adenocarcinoma Outcomes: A Secondary Analysis of a Prospective Phase 2 Trial
Speaker: Keaton Rummel, MD - Mayo Clinic College of Medicine and Science Rochester, Rochester -
02:30pm - 03:45pm PT
Extended-Field Definitive Chemoradiation for Patients with Anal Squamous Cell Carcinoma with Nodal Metastatic Disease
Speaker: Elisa Liu, MD, BS - Memorial Sloan Kettering Cancer Center, New York -
02:30pm - 03:45pm PT
External Beam Radiotherapy (EBRT) + Immunotherapy (IO) in the Management of Hepatobiliary Malignancies: A Meta-Analysis of Treatment Response Rates
Speaker: Juan Jose Juarez Vignon Whaley, MD - Beth Israel Deaconess Medical Center, Boston -
02:30pm - 03:45pm PT
FAP-Targeted PET/CT with [18F]AlF-NOTA-FAPI-04 in Hepatocellular Carcinoma: Prospective Correlation of Fibrosis Quantification with Treatment Response and Survival Outcomes
Speaker: Chen Wang, MD - Shandong Cancer Hospital and Institute, Jinan -
02:30pm - 03:45pm PT
Feasibility and Safety of Black Soybean Extract Cream on Radiation-Induced Dermatitis, Pain and Quality of Life in Head and Neck Cancer Patients: A Phase I, Single-Arm, Open-Label Prospective Study
Speaker: Hain-Hua Lee, MD - Kaohsiung Medical University, Kaohsiung City -
02:30pm - 03:45pm PT
Feasibility of 3 Fraction Treatment Using Stereotactic Magnetic Resonance - Guided Adaptive Radiation Therapy in Single or Three Fractions for Oligometastases in the Abdomen and Pelvis: Results from the Phase I SMART-STOP 3-Fraction Cohort
Speaker: Zoe Cosner, MD - Harvard Radiation Oncology Program, Boston -
02:30pm - 03:45pm PT
Feasibility of Serial Tumor-Informed ctDNA Testing to Assess Response to Chemoradiation in Esophageal Cancer
Speaker: Abraham Wu, MD - Memorial Sloan Kettering Cancer Center, New York -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Four-Year Results of a Phase I/II Single-Arm Prospective Clinical Trial of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART) for Metachronous Oligometastatic Abdominopelvic Lymph Node and Soft Tissue Metastases
Speaker: Thomas Howard, MD, PhD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Gamma Knife-Mimicking Radiosurgery with Cyberknife: A Comparison of Dose Prescription Methodologies for Treatment of Trigeminal Neuralgia
Speaker: Alan Monroe, MD - Penrose Cancer Center, Colorado Springs -
02:30pm - 03:45pm PT
Gut Microbiome and Metabolic Traits in Immunotherapy-Based Total Neoadjuvant Therapy for MSS Locally Advanced Rectal Cancer: A Longitudinal Cohort Study
Speaker: Weiqing Lu, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Cente, Shanghai -
02:30pm - 03:45pm PT
Heel Spur Radiotherapy: Prospective Randomized Clinical Trial
Speaker: Petr Burkon, MD, PhD - Masaryk Memorial Cancer Institute, Brno -
02:30pm - 03:45pm PT
Hepatobiliary Toxicity Following Ablative Radiation for Centrally Located Hepatocellular Carcinoma (HCC)
Speaker: Sarah Feldkamp, MD - University of Cincinnati, Cincinnati -
02:30pm - 03:45pm PT
High Rates of Local Failure in the Triangle Volume for Non-Irradiated Borderline Resectable and Locally Advanced Pancreatic Cancer
Speaker: I-Chia Liu, MD - Johns Hopkins Radiation Oncology Kimmel Cancer Center, Baltimore -
02:30pm - 03:45pm PT
Hypofractionated Pelvic Radiotherapy for Symptom Control in Metastatic Rectal Cancer: A Retrospective Analysis
Speaker: Ningyu Wang, MD - Cancer center of China, Beijing -
02:30pm - 03:45pm PT
Hypofractionated Radiotherapy Combined with Immunotherapy and Chemotherapy for Locally Recurrent Rectal Cancer (TORCH-R): A Prospective, Single-Arm, Two-Cohort, Phase II Trial
Speaker: Ruiyan Wu, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai -
02:30pm - 03:45pm PT
ICD Coding an 3D Target Volume Definitions for Benign Diseases: An International Delphi Consensus Process
Speaker: Heinrich Seegenschmiedt, MD, PhD, Professor - MVZ Ruhrradiologie Rur191, Essen -
02:30pm - 03:45pm PT
Identifying Risk Factors and Evaluating Therapeutic Interventions for Anastomotic Recurrence in Postoperative Esophageal Squamous Cell Carcinoma
Speaker: Wei Huang, MD, PhD - Shandong Cancer Hospital, Jinan -
02:30pm - 03:45pm PT
Impact of Elective Nodal Irradiation (ENI) vs. Involved Field Irradiation (IFI) on Estimated Dose Radiation to Immune Cells (EDRIC) and Prognostic Analysis in Esophageal Carcinoma
Speaker: Xuejiao Ren, MD - Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Impact of HRD Status and DDR Pathway Genes on Chemoradiotherapy Effectiveness in Chinese Esophageal Cancer Patients
Speaker: Jingping Yu, PhD - Radiotherapy Department, Changzhou Cancer Hospital, Changzhou, Jiangsu Province, 213032, China, Changzhou -
02:30pm - 03:45pm PT
Impact of Muscle Mass Loss on Survival during Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Multi-Center Retrospective Study in China (TIMES Study)
Speaker: Jie Zhu, MD - Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan Province, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Scienc, Chengdu -
02:30pm - 03:45pm PT
Impact of Preoperative Ablative Radiation after Induction Chemotherapy for Borderline Resectable Pancreatic Adenocarcinoma
Speaker: Alden DSouza, MD, MPHS - Washington University School of Medicine, Saint Louis -
02:30pm - 03:45pm PT
Impact of Prior Primary Care Utilization on Metastatic Disease and Mortality in Colorectal Cancer
Speaker: Sakshith Reddy Chintala, - University of California San Diego Health, San Diego -
02:30pm - 03:45pm PT
Impact of Radiation Therapy on Survival in Hepatocellular Carcinoma with Vascular Tumor Thrombus: A Retrospective Analysis of Systemic Therapy Combinations
Speaker: Eleni Kohilakis, MD - Albert Einstein College of Medicine, Bronx -
02:30pm - 03:45pm PT
Impact of Stomatitis on the Efficacy of QUAD SHOT for Head and Neck Cancer: A Prospective Study
Speaker: Osamu Tanaka, MD, PhD - Asahi Univeristy Hospital, Gifu city -
02:30pm - 03:45pm PT
Impact of Subcutaneous Adipose Tissue Area Change during Neoadjuvant Chemoradiotherapy on Disease-Free Survival and Tumor Response in Patients with Locally Advanced Rectal Cancer
Speaker: Qing Yang, - Department of General Surgery, Peking University Third Hospital, Beijing, China, Beijing -
02:30pm - 03:45pm PT
Impact of Subcutaneous and Visceral Fat in Patients Receiving Ablative Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Cancer
Speaker: Adeel Kaiser, MD - Miami Cancer Institute, Miami -
02:30pm - 03:45pm PT
Impact of the NRF-2/KEAP-1 Signaling Pathway on Treatment Response in Rectal Cancer Patients Treated with Neoadjuvant Chemo-Radiotherapy
Speaker: Hatice Kubra Gunduz, MD - Marmara University Pendik Education and Research Hospital Radiation Oncology Clinic, Istanbul -
02:30pm - 03:45pm PT
Impact of Time to Treatment on the Development of Distant Metastasis in Localized Pancreatic Cancer: A Tertiary Care Center Experience.
Speaker: Marisa Siebel, MD - Northwell Health, Lake Success -
02:30pm - 03:45pm PT
Improving Dysphagia Relief and Patient Throughput in Advanced Esophageal Cancer with Brachytherapy in Resource-Limited Settings
Speaker: Ajay Choubey, MBBS, DNB - Homi Bhabha Cancer Hospital and Research Centre, varanasi -
02:30pm - 03:45pm PT
Incorporating Electroanatomic Mapping Data into Radiation Treatment Planning for Stereotactic Cardiac Radioablation: A One-Year Follow-up
Speaker: Khashayar Fattah, MD - University of Texas Southwestern Medical Center, Dallas -
02:30pm - 03:45pm PT
Influence of Pancreatic Ductal Adenocarcinoma Anatomic Tumor Subregion on Oncologic Outcomes Following MRI-Guided Stereotactic Body Radiotherapy
Speaker: Rojine Ariani, MD, MS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles -
02:30pm - 03:45pm PT
Initial Clinical Results of Four-Dimensional CT-Guided Online Adaptive Radiotherapy for Advanced Gastric Cancer
Speaker: Hong Ma, MD, PhD - Tongji Hospital Affiliated to Tongji Medical College of Huazhong University, Wuhan -
02:30pm - 03:45pm PT
Inpatient Radiotherapy: Insights for Hemostasis Consults
Speaker: Simran Polce, MD - Moffitt Cancer Center, Tampa -
02:30pm - 03:45pm PT
Insights and Impact of a Dedicated Inpatient Radiation Oncology Service
Speaker: Emily Keit, MD - Moffitt Cancer Center, Tampa -
02:30pm - 03:45pm PT
Integration of Dose, Imaging Biomarkers, and 3D Topological Information via Transformer-GNN for Multimodal Learning in Predicting Radiation-Induced Lung Injury in Elderly Esophageal Cancer Patients
Speaker: Xin Yang, MS - Chongqing University Cancer Hospital, Shapingba -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
International Delphi Consensus on Endpoints Selection, Reporting, and Clinical Response Criteria for SBRT in Bone Metastases
Speaker: Shing Fung Lee, MBBS - National University Hospital, Singapore -
02:30pm - 03:45pm PT
Jianzhong Qushi Formula for Treating Chronic Radiation Induced Proctitis with Deficiency Syndrome: A Protocol for a Multicenter, Prospective, Randomized Controlled Clinical Trial (ACORN STUDY)
Speaker: Yiyuan Cui, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing -
02:30pm - 03:45pm PT
KRAS Mutations as Predictor of Radioresistance in Pulmonary Metastases from Colorectal Cancer
Speaker: Mauro Loi, MD - Azienda Ospedaliera Universitaria Careggi, Florence -
02:30pm - 03:45pm PT
Laboratory and Dosimetric Predictors for Short Term Survival and Toxicity for HCC Patients Treated with SBRT
Speaker: Seyyedeh Azar Oliaei Motlagh, - University of Michigan, Ann Arbor -
02:30pm - 03:45pm PT
LINAC-based Stereotactic Ablative Radiotherapy (SABR) for Pancreatic Cancer: Toxicity Profile and Outcomes
Speaker: Yen-Ruh Wuu, MD - Northwell Health, Lake Success -
02:30pm - 03:45pm PT
Long-Term Outcomes of Intraoperative Electron Radiotherapy (IOERT) in Locally Advanced and Recurrent Colorectal Cancer: A Single-Institution Experience
Speaker: Khaled Hassan, MD, MBBS - Kasr Al-Ainy Center of Radiation Oncology and Nuclear Medicine, Cairo -
02:30pm - 03:45pm PT
Low Dose Radiation Therapy (LDRT) for Osteoarthritis: A Retrospective Study of 59 Patients and 94 Joints Treated
Speaker: Nayan Shah, - University of Florida, Gainesville -
02:30pm - 03:45pm PT
Low Dose Radiotherapy in Treatment of Recalcitrant Hidradenitis Suppurativa
Speaker: Robert Walker, - Thomas Jefferson University Hospital, Philadelphia -
02:30pm - 03:45pm PT
Low-Dose Radiotherapy for Interstitial Cystitis
Speaker: Michael Nolan, DVM, PhD - North Carolina State University, Raleigh -
02:30pm - 03:45pm PT
Low-Dose Radiotherapy for Painful Musculoeskeltal Disorders: 10 Years Follow-Up
Speaker: Beatriz Alvarez, MD - Hospital Universitary HM Sanchinarro, Madrid -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Modest Dose Escalation for Early-Stage Anal Cancer: Cancer Control and Toxicity Outcomes
Speaker: Sage Copling, BS - MD Anderson Cancer Center, Houston -
02:30pm - 03:45pm PT
MR-Guided Adaptive Radiotherapy for Primary Liver Cancer: Impact of Online Isotoxic Prescriptions Near Organs-at-Risk
Speaker: Haruo Inokuchi, MD, PhD - Department of Radiation Oncology, Graduate School of Medicine, Osaka Metropolitan University, Osaka -
02:30pm - 03:45pm PT
MR-Guided Adaptive Stereotactic Ablative Radiotherapy for Postoperative Recurrent and Metastatic Pancreatic Cancer: Early Efficacy and Toxicity Outcomes
Speaker: Chen Wang, MD - Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing -
02:30pm - 03:45pm PT
MRI-Simulator and MR-Linac in Esophageal and Gastric Cancers: An Imaging-Pathology Correlation Study
Speaker: Su Chen Fong, MBBS - Peter MacCallum Cancer Centre, Heidelberg -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Multivariate Analysis of Outcomes of Palliative Radiotherapy and Re-Irradiation in Children
Speaker: Faisal Habbab, - Cross Cancer Institute, Edmonton -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Neoadjuvant Therapy Approaches for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Speaker: Chia Ching Lee, MD - National University Cancer Institute Singapore, Singapore -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Neuropsychological Screening, Advance Care Planning, and End-of-Life Care Among Vulnerable Older Adults Undergoing Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Speaker: Leah Thompson, MD - Harvard Radiation Oncology Program, Boston -
02:30pm - 03:45pm PT
Neurostructural Paradox in Trigeminal Neuralgia: VBM Reveals Pain Network Remodeling after Radiosurgery
Speaker: Vangipuram Shankar, MD, MBBS - C r reddy superspeciality hospital, Nellore -
02:30pm - 03:45pm PT
Non-Surgical Management of Rectal Adenocarcinoma in a Safety-Net Hospital System: Outcomes and Implications for Watch and Wait Strategies
Speaker: Ashley Chavana, BS - Baylor College of Medicine, Houston -
02:30pm - 03:45pm PT
Oncological Outcomes of Dose-Escalated Chemoradiotherapy Vs. Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Retrospective Analysis
Speaker: Abdullah Alswilem, MBBS - King Saud University Medical City, Riyadh -
02:30pm - 03:45pm PT
Opioid-Related Hospitalizations and Benzodiazepine Co-Prescription in Older Cancer Survivors
Speaker: Paul Riviere, MD - UCSD Radiation Medicine and Applied Sciences, La Jolla -
02:30pm - 03:45pm PT
Optimization of Radiotherapy Modality in Elderly Esophageal Cancer Patients: A Decade-Long Retrospective Survival Analysis
Speaker: Yan Luo, - Cancer hospital, Chongqing University, Chongqing -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Organ Preservation in Locally Advanced Rectal Cancer Treated with Contact X-Ray Brachytherapy: A Systematic Review and Single-Arm Meta-Analysis
Speaker: Adriana Dominguez Ayala, MD - Centro Medico Nacional 20 de Noviembre, Mexico City -
02:30pm - 03:45pm PT
Outcomes in Borderline Resectable Pancreatic Cancer: Impact of Integrated Pathologic Score
Speaker: Torrin Jacobsen, MS, BS - Lake Erie College of Osteopathic Medicine Bradenton, Tampa -
02:30pm - 03:45pm PT
Outcomes of Extensive-Stage Small-Cell Esophagus Cancer Patients Treated with Different Treatment Modalities: A Multi-Institutional Retrospective Analysis
Speaker: Wei Huang, PhD - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, jinan -
02:30pm - 03:45pm PT
Outcomes of Re-Irradiation with Pencil Beam Scanning Proton Therapy for Rectal Cancer Following Prior Pelvic Radiation: Toxicity, Recurrence, and Symptom Improvement
Speaker: Austin Thompson, MD - University of Maryland Medical Center, Baltimore -
02:30pm - 03:45pm PT
Pain Response to Palliative Radiation Therapy in Korean American Cancer Patients with Metastases to Bone
Speaker: Iris Kang, BS - Keck School of Medicine of USC, Los Angeles -
02:30pm - 03:45pm PT
Palliative Radiotherapy within the Last 30 Days of Life: A Multi-Site Review of Practice Patterns
Speaker: Van Handke, - MD Anderson Cancer Center, Houston -
02:30pm - 03:45pm PT
Pancreatic Reirradiation: A Multi-Institutional Retrospective Analysis of Feasibility, Tolerability and Clinical Outcomes
Speaker: Helen Hou, - Department of Radiation Oncology, TUM University Hospital, Munich -
02:30pm - 03:45pm PT
Perioperative Radiation Therapy for Prevention of Recurrent Arthrofibrosis after Revision Total Knee Arthroplasty
Speaker: Jason Liu, BS - University of Central Florida Medical School, Orlando -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Phased Relief : Optimizing Dose for Bilateral Trigeminal Neuralgia Radiosurgery
Speaker: Vangipuram Shankar, MD, MBBS - C r reddy superspeciality hospital, Nellore -
02:30pm - 03:45pm PT
PIVKA-II as an Adjunct Biomarker to AFP for the Assessment of the Early Radiographic Treatment Response to SBRT in HCC
Speaker: Srinjoy Sil, MD, PhD - NYU Langone Medical Center, New York -
02:30pm - 03:45pm PT
PLDR Chemoradiation for Esophageal and Lung Cancer is Associated with Low Rates of Severe Esophagitis
Speaker: Joshua Meyer, MD - Fox Chase Cancer Center, Philadelphia -
02:30pm - 03:45pm PT
Precision Prevention of Pancreatic Cancer: Developing Absolute Risk Assessment Using a Machine Learning-Based Risk Prediction Model Integrating Polygenic Risk Scores (PRS) in the UK Biobank Cohorts and Its Application in a UK Community Setting
Speaker: Te-Min Ke, MD, PhD - Chi Mei Medical Center, Yungkang City 701 44 -
02:30pm - 03:45pm PT
Predicting Pathologic Complete Response following Clinical Complete Response in Esophageal Carcinoma
Speaker: Mihir Karande, MD - Fox Chase Cancer Center, Philadelphia -
02:30pm - 03:45pm PT
Predictors of Pathologic and Radiologic Response in Patients with HCC Treated with SBRT Prior to Transplant
Speaker: Evrosina Isaac, MD - Virginia Commonwealth University Health System, Richmond -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Prognostic Predictive Role of Short-Term Efficacy Indicators in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Speaker: Ningyu Wang, MD - Cancer center of China, Beijing -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
PSMA-PET Guided Metastasis-Directed Therapy
Speaker: Elitza Koutleva, MD, MBA - University of North Carolina at Chapel Hill, Chapel Hill -
02:30pm - 03:45pm PT
Quality of Life Assessment of Palliative Radiotherapy for Patients with Low-risk Asymptomatic Bone Metastasis: A Prospective Observational Study
Speaker: Yutaro Koide, MD, PhD - Aichi Cancer Center Hospital, Nagoya -
02:30pm - 03:45pm PT
Radiation Therapy for Cancer Pain with and without a Neuropathic Component: A Single-Center Prospective Observational Study
Speaker: Kohsei Yamaguchi, MD - Amakusa Central Hospital, Amakusa -
02:30pm - 03:45pm PT
Radiosurgery Outcomes in Pure Venous Conflict Trigeminal Neuralgia Efficacy, Safety, and Long-term Outcomes
Speaker: Vangipuram Shankar, MD, MBBS - C r reddy superspeciality hospital, Nellore -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Radiotherapy Combined with Systemic Therapy vs. Systemic Therapy Alone for Recurrent or Metastatic Esophageal Cancer: A Systematic Review and Meta-Analysis
Speaker: Jun Wang, MD, PhD - Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Radiotherapy of Dupuytrens Contracture following Collagenase Treatment
Speaker: Colton Cox, BS - University of Nevada Reno School of Medicine, Reno -
02:30pm - 03:45pm PT
Radiotherapy-Boosted Thymosin Alpha-1 Based Immunotherapy: A Cutting-Edge Approach to Amplifying Immune Dynamics and Therapeutic Efficacy in Advanced Solid Tumors
Speaker: Yuehong Kong, - The Second Affiliated Hospital of Soochow University, ??? -
02:30pm - 03:45pm PT
Rapid Response Palliative Radiotherapy Program (RAPRT): Experience with a Non-Classical Model
Speaker: Isidora King, MD - Clinica IRAM, Santiago -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Reirradiation for Abdominal GastroIntestinal Malignancies: A Systematic Review by the Reirradiation Collaborative Group (ReCOG)
Speaker: Nauman Malik, MD, MS - Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto -
02:30pm - 03:45pm PT
Reirradiation with SBRT in Radiorecurrent Prostate Cancer ? Impact on Disease Control and Quality of Life Outcomes
Speaker: Papaiah Susheela Sridhar, MD - Healthcare Global Enterprises Ltd., Bangalore -
02:30pm - 03:45pm PT
Relationship of PD-L1 Status and Outcomes in a Diverse Patient Population with Anal Squamous Cell Carcinoma
Speaker: Daniel Cherry, MD, MAS - Mount Sinai Hospital, New York -
02:30pm - 03:45pm PT
Risk Factors for Lateral Pelvic Lymph Node Metastasis in Rectal Cancer
Speaker: Özge Duran Can, MD - Celal Bayar University, Faculty of Medicine, Department of Radiation Oncology, Manisa -
02:30pm - 03:45pm PT
Risk of Vertebral Compression Fractures after Hypofractionated Spine Stereotactic Body Radiation Therapy
Speaker: Zhen Li, - Zhongshan Peoples Hospital, Zhongshan -
02:30pm - 03:45pm PT
Role of Intraoperative Radiotherapy in Hepatocellular Carcinoma following Narrow-Margin Hepatectomy: A Single Institutional Long-Term Follow Up Analysis
Speaker: Mengyuan Li, - State Key Laboratory of Molecular Oncology, Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (, Beijing -
02:30pm - 03:45pm PT
Sacral and Other Pelvic Bone Fractures Following Short-Course Radiation Therapy and Consolidation Chemotherapy for Rectal Cancer
Speaker: Panos Papanikolaou, MD - Johns Hopkins Hospital, Baltimore -
02:30pm - 03:45pm PT
Safe Delivery of Ablative, Non-Adaptive Pancreas and Elective Nodal RT in Borderline Resectable and Locally Advanced Pancreatic Cancer
Speaker: Reine Abou Zeidane, MD - Case Western Reserve School of Medicine, Cleveland -
02:30pm - 03:45pm PT
Short-Course Radiotherapy, Chemotherapy and Surgery in Rectal Cancer Patients under 50: Recurrence and Survival Outcomes
Speaker: David Simson, MBBS - Rajiv Gandhi Cancer Institute and Research Centre, New Delhi -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Stereotactic Ablative MR-Guided Online Adaptive Radiation Therapy (SMART) for Management of Borderline Resectable and Locally Advanced Pancreatic Carcinoma
Speaker: Neris Dincer, MD - Radiation Oncology Department, Acibadem Mehmet Ali Aydinlar University School of Medicine, Istanbul, Turkey, Istanbul -
02:30pm - 03:45pm PT
Stereotactic Body Radiation Therapy for Adrenal Metastases: Evaluation of Efficacy and Toxicity Outcomes.
Speaker: Mohammad Alsmairat, MD - King Hussein Cancer Center, Amman -
02:30pm - 03:45pm PT
Stereotactic Body Radiation Therapy for Ventricular Tachycardia is Safe and Effective: Results from a Large Retrospective Cohort
Speaker: John Chojnowski, MD - Hospital of the University of Pennsylvania, Philadelphia -
02:30pm - 03:45pm PT
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) with and without Liver Transplant in Patients with Advanced Hepatic Cirrhosis.
Speaker: Parisa Shamsesfandabadi, MD - Allegheny Health Network, Pittsburgh -
02:30pm - 03:45pm PT
Stereotactic Body Radiation Therapy (SBRT) vs. Irreversible Electroporation (IRE) in the Treatment of Locally Advanced Pancreatic Cancer, A Systematic Review and Meta-Analysis Comparing Median Overall Survival and Severe Adverse Events
Speaker: Deniz Demircioglu, - Medical College of Wisconsin, Milwaukee -
02:30pm - 03:45pm PT
Stereotactic body radiation therapy with PD-1 inhibitor for locally advanced or locoregionally recurrent pancreatic cancer (preSPARK-1 study)
Speaker: Yi Chen, MD - Peking University Third Hospital, Beijing -
02:30pm - 03:45pm PT
Stereotactic body radiotherapy for Osseous Low Alpha-beta Resistant metastases for Pain relief - SOLAR-P
Speaker: Stephan Tran, MD, BS, MBS - Mcmaster University, Hamilton -
02:30pm - 03:45pm PT
Stereotactic body radiotherapy (SBRT) in the treatment of oligometastatic breast cancer: A multi-institutional feasibility trial
Speaker: Elysia Donovan, MD, MS - Sunnybrook Odette Cancer Center, Toronto -
02:30pm - 03:45pm PT
Stereotactic radioablation to ventricular tachycardia: prospective phase I study in Asian country
Speaker: Mariko Kawamura, MD, PhD - Nagoya University hospital, Nagoya -
02:30pm - 03:45pm PT
Study of relationship between proton beam therapy to liver cancers and persistent pleural effusion
Speaker: Sae Matsumoto, MD - Kanazawa University Hospital, Kanazawa -
02:30pm - 03:45pm PT
Surgical Outcomes In Locally Advanced Rectal Cancer Following Preoperative Chemoradiation With Simultaneous Integrated Boost (SIB-CRT)
Speaker: Mauro Loi, MD - Azienda Ospedaliera Universitaria Careggi, Florence -
02:30pm - 03:45pm PT
Systemic Therapy With or Without Local Radiotherapy for Advanced Esophageal Carcinoma: A Systematic Review and Meta-analysis
Speaker: Xiaoxi Chen, - Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
The Impact of Immunotherapy on Splenomegaly and Thrombocytopenia in Locally Advanced Rectal Cancer Patients Undergoing Total Neoadjuvant Therapy
Speaker: Mingxu Yan, - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai -
02:30pm - 03:45pm PT
The Impact of Tumor-Induced Nutritional Disorders on the Relationship between G8 Scores and Definitive Radiotherapy Strategies
Speaker: Ikuno Nishibuchi, MD, PhD - Department of Radiation Oncology, Hiroshima University, Hiroshima -
02:30pm - 03:45pm PT
The Importance of Lymphopenia Severity in Anal Cancer Patients Undergoing Definitive Therapy
Speaker: Dulguun Myagmarsuren, BS - Virginia Tech Carilion School of Medicine, Roanoke -
02:30pm - 03:45pm PT
The Predictive Value of Pretreatment Peripheral T-Lymphocyte Subsets for Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma Patients Undergoing Neoadjuvant Chemoradiotherapy: A Prospective Cohort Analysis
Speaker: Mengdi Wang, MD - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai -
02:30pm - 03:45pm PT
The Relationship between Liver Metastasis Shrinkage Rate and Quantitative Values in Lu-177 DOTATATE Therapy for Somatostatin Receptor-Positive Neuroendocrine Tumors
Speaker: Kenta Konishi, MD, PhD - Hamamatsu University School of Medicine, Hamamatsu -
02:30pm - 03:45pm PT
Time-Dependent Toxicity Modeling and Local Control in BID Thoracic Reirradiation: Implications for Personalized Radiotherapy
Speaker: Cecilia de Sousa, MD, MPH - Johns Hopkins Medicine, Baltimore -
02:30pm - 03:45pm PT
To Explore the Efficacy and Safety of Neoadjuvant Chemoradiotherapy in Locally Advanced Colon Cancer: A Systematic Review and Meta-Analysis
Speaker: Jingyi Sun, - The Fourth Hospital of Hebei Medical University, Shijiazhuang -
02:30pm - 03:45pm PT
Tracing the Pain Circuits: FCD as a Biomarker for Radiosurgery in Trigeminal Neuralgia
Speaker: Vangipuram Shankar, MD, MBBS - C r reddy superspeciality hospital, Nellore -
02:30pm - 03:45pm PT
Treatment Patterns and Outcomes in Elderly Patients with Cholangiocarcinoma
Speaker: Jino Park, MD - University of California Irvine, Orange -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
Utility of Screening for Oligometastatic Disease: A Systematic Review
Speaker: Alysa Fairchild, MD - Cross Cancer Institute, Edmonton -
02:30pm - 03:45pm PT
Utilization of 4D-CBCT in lieu of Intra-Hepatic Fiducial Markers for Tumor Localization in Liver SBRT - Description of a Novel Technique and Clinical Outcomes in a Retrospective Cohort
Speaker: Jacob Oyeniyi, MD - Corewell Health William Beaumont University Hospital, Royal Oak -
02:30pm - 03:45pm PT
Utilization Rates of Local Hemostatic Treatments for Gastric Cancer: A Survey Based on a Nationwide Claims Database
Speaker: Yuki Wada, MD, PhD - Akita University Graduate School of Medicine, Akita -
02:30pm - 03:45pm PT
-
02:30pm - 03:45pm PT
White Matter Fingerprints: Tract-Specific DTI Predictors for Radiosurgical Thalamotomy in Parkinsons Tremor
Speaker: Vangipuram Shankar, MD, MBBS - C r reddy superspeciality hospital, Nellore